Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
Crossref DOI link: https://doi.org/10.1007/s13300-020-00910-1
Published Online: 2020-08-28
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kuang, Jian
Zhu, Jiankun
Liu, Siying
Li, Quanmin
Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2020-08-28
Version of Record valid from 2020-08-28
Article History
Received: 22 July 2020
First Online: 28 August 2020